The heparins, well-known for their anticoagulant properties, may also have anti-
inflammatory effects that could contribute to their effectiveness in the treatment of venous …

Importance Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to
112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from …

Blood-contacting medical devices of different biomaterials are often used to treat various
cardiovascular diseases. Thrombus formation is a common cause of failure of …

Importance Varicose veins are common but rarely associated with serious health risks. Deep
venous thrombosis (DVT), pulmonary embolism (PE), and peripheral artery disease (PAD) …

Background To investigate the risk of first-time acute coronary syndrome (ACS), stroke and
venous thromboembolism (VTE) in patients with ankylosing spondylitis (AS), psoriatic …

Background Reports of the crude incidence of venous thromboembolism (VTE) in Western
countries vary widely. Data regarding risk factors, incidence and recurrence of VTE from …

Events mediated by the P-selectin/PSGL-1 pathway play a critical role in the initiation and
propagation of venous thrombosis by facilitating the accumulation of leukocytes and …

Janus kinase (JAK) inhibitors have been developed as disease-modifying antirheumatic
drugs. Despite the positive therapeutic impacts of JAK inhibitors, concerns have been raised …

Multiple factors contribute to the risk of venous thromboembolism (VTE). Platelets have
attracted much interest in arterial cardiovascular disease, whereas their role in VTE has …

High platelet to lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR) are
associated with an increased risk of arterial thrombosis, but their role in venous …